About DARWIN BIOSCIENCES, INC.
Darwin Biosciences is a company that develops a point-of-care diagnostic platform using saliva-based testing for early disease detection, with applications in both military and commercial markets. The company was founded in 2020 and has pivoted into various diagnostic solutions, including sepsis and infectious disease detection.
Point-of-care diagnostic device using saliva samplesDetection of immune signatures indicative of acute-phase infectionsNon-invasive testing methodBroad infection detection across pathogen typesScalable platform for various disease applicationsRNA amplification and processing without laboratory or power dependency
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| RAPID DIAGNOSTIC ASSAYS FOR SELF-MONITORING OF ACUTE OR REBOUND HIV-1 INFECTION | Department of Health and Human Services | $299K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DARWIN BIOSCIENCES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.